{
  "schema_version": "0.1.0",
  "id": "fda-drug-shortage:rocuronium-bromide-injection",
  "slug": "rocuronium-bromide-injection",
  "title": "FDA shortage status: Rocuronium Bromide Injection",
  "ingredient": "Rocuronium Bromide Injection",
  "status": "current",
  "source_statuses": [
    "Current"
  ],
  "brand_names": [
    "ROCURONIUM",
    "ROCURONIUM BROMIDE"
  ],
  "therapeutic_categories": [
    "Anesthesia"
  ],
  "dosage_forms": [
    "Injection"
  ],
  "routes": [
    "INTRAVENOUS"
  ],
  "package_count": 26,
  "packages": [
    {
      "package_ndc": "43066-013-10",
      "product_ndc": "43066-007",
      "company_name": "Baxter Healthcare",
      "manufacturer_name": "Baxter Healthcare Corporation",
      "presentation": "Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 43066-013-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "02/15/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "43066-007-10",
      "product_ndc": "43066-007",
      "company_name": "Baxter Healthcare",
      "manufacturer_name": "Baxter Healthcare Corporation",
      "presentation": "Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 43066-007-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "02/15/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-226-10",
      "product_ndc": "55150-225",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 55150-226-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "02/15/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-225-05",
      "product_ndc": "55150-225",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 55150-225-05)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "02/15/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-426-05",
      "product_ndc": "63323-426",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-05)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/15/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-426-10",
      "product_ndc": "63323-426",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/15/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "65219-065-05",
      "product_ndc": "65219-065",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-065-05)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/15/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "65219-442-05",
      "product_ndc": "65219-442",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-442-05)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/15/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "65219-444-10",
      "product_ndc": "65219-442",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-444-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/15/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0143-9250-10",
      "product_ndc": "0143-9250",
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Hikma Pharmaceuticals USA Inc.",
      "presentation": "Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9250-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/13/2026",
      "initial_posting_date": "02/15/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0143-9251-10",
      "product_ndc": "0143-9250",
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Hikma Pharmaceuticals USA Inc.",
      "presentation": "Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9251-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/13/2026",
      "initial_posting_date": "02/15/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-5160-10",
      "product_ndc": "0409-1403",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-5160-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/15/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-7037-10",
      "product_ndc": "0409-3189",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-7037-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/15/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-1403-10",
      "product_ndc": "0409-1403",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-1403-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/15/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-3189-10",
      "product_ndc": "0409-3189",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-3189-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/15/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "71288-700-06",
      "product_ndc": "71288-700",
      "company_name": "Meitheal Pharmaceuticals, Inc.",
      "manufacturer_name": "Meitheal Pharmaceuticals Inc.",
      "presentation": "Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-700-06)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "06/01/2026",
      "initial_posting_date": "02/15/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "71288-718-11",
      "product_ndc": "71288-700",
      "company_name": "Meitheal Pharmaceuticals, Inc.",
      "manufacturer_name": "Meitheal Pharmaceuticals Inc.",
      "presentation": "Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-718-11)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "06/01/2026",
      "initial_posting_date": "02/15/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "67457-228-05",
      "product_ndc": "67457-228",
      "company_name": "Mylan Institutional, a Viatris Company",
      "manufacturer_name": "Mylan Institutional LLC",
      "presentation": "Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-05)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/20/2026",
      "initial_posting_date": "02/15/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "67457-228-10",
      "product_ndc": "67457-228",
      "company_name": "Mylan Institutional, a Viatris Company",
      "manufacturer_name": "Mylan Institutional LLC",
      "presentation": "Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/20/2026",
      "initial_posting_date": "02/15/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "66794-229-41",
      "product_ndc": "66794-228",
      "company_name": "Piramal Critical Care Inc.",
      "manufacturer_name": "Piramal Critical Care Inc",
      "presentation": "Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 66794-229-41)",
      "availability": "Limited Availability",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/15/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "66794-228-41",
      "product_ndc": "66794-228",
      "company_name": "Piramal Critical Care Inc.",
      "manufacturer_name": "Piramal Critical Care Inc",
      "presentation": "Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 66794-228-41)",
      "availability": "Limited Availability",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/15/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "25021-687-05",
      "product_ndc": "25021-687",
      "company_name": "Sagent Pharmaceuticals",
      "manufacturer_name": "Sagent Pharmaceuticals",
      "presentation": "Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 25021-687-05)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "02/15/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0781-3220-92",
      "product_ndc": "0781-3220",
      "company_name": "Sandoz Inc.",
      "manufacturer_name": "Sandoz Inc",
      "presentation": "Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-92)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "02/15/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0781-3220-95",
      "product_ndc": "0781-3220",
      "company_name": "Sandoz Inc.",
      "manufacturer_name": "Sandoz Inc",
      "presentation": "Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-95)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "02/15/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "39822-4200-6",
      "product_ndc": "39822-4200",
      "company_name": "XGen Pharmaceuticals DJB, Inc.",
      "manufacturer_name": "XGen Pharmaceuticals DJB, Inc.",
      "presentation": "Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 39822-4200-6)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "02/15/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "39822-4200-2",
      "product_ndc": "39822-4200",
      "company_name": "XGen Pharmaceuticals DJB, Inc.",
      "manufacturer_name": "XGen Pharmaceuticals DJB, Inc.",
      "presentation": "Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 39822-4200-2)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "02/15/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    }
  ],
  "availability_counts": {
    "Available": 23,
    "Limited Availability": 2,
    "Unavailable": 1
  },
  "initial_posting_date": "02/15/2023",
  "latest_source_update": "08/20/2026",
  "source_updated_at": "2026-08-22",
  "official_url": "https://api.fda.gov/drug/shortages.json",
  "source_name": "U.S. Food and Drug Administration openFDA Drug Shortages",
  "source_license_url": "https://open.fda.gov/license/",
  "retrieved_at": "2026-08-22T15:54:11+00:00",
  "unknowns": {
    "local_availability": "Unknown. FDA status is nationwide and is not local inventory.",
    "clinical_alternatives": "Not provided. CiteFacts does not publish treatment or substitution advice.",
    "resolution_date": "Unknown unless an FDA source row provides an update date."
  },
  "derivations": {
    "status": "current when a grouped FDA row has Current; otherwise it preserves the available FDA Resolved, Discontinuation, or not-current state.",
    "ingredient_page": "Grouped by FDA generic_name, falling back to openFDA.generic_name.",
    "availability_counts": "Count of non-empty FDA package availability values; it is not a claim about local supply."
  }
}